heart rate variability test

heart rate variability test

A test that measures swings in heart rate over 24 hours via a Holter (portable EKG) monitor, identifying high-risk congestive heart failure patients. If heart rate variability is high, the prognosis is good; if low, therapy may be adjusted to reduce the risk of congestive heart failure.

heart rate variability test

Swing test Cardiology A test that measures swings in heart rate over 24 hrs via a portable EKG, identifying high-risk CHF Pts; if HRV is high, prognosis is good; if low, treatment is adjusted to prevent early demise. See Chaos theory.
References in periodicals archive ?
com), the pioneer of office and hospital-based, non-invasive systems for measurement of heart rate variability (HRV), today announced that its Anscore(TM) Health Management System, an easy-to-use heart rate variability test, will be demonstrated at the 28th annual meeting of the American Association of Diabetes Educators in August.
The Anscore Health Management System is a non-invasive, easy to perform heart rate variability test designed for office-based use.
com), the pioneer of office-based, non-invasive systems for measurement of heart rate variability (HRV), today announced that its Anscore(TM) Health Management System, an office-based, easy-to-use heart rate variability test, will be demonstrated at the ADA's annual meeting on June 22-26 in Philadelphia.
The Company's third 510(k) approval from the FDA on April 26, 2001 allows the Anscore System to report normal ranges for heart rate variability based on device-specific reference values, a milestone not achieved by any other heart rate variability test on the market.
A heart rate variability test is the only non-invasive procedure that can detect these insidious changes.
Receiving a third 510(k) represents a tremendous achievement for our engineering staff and proprietary technology, which delivers test data with a degree of accuracy that is unusually high by any medical application standard and has certainly never been seen before with any other heart rate variability test.
Boston Medical Technologies, the pioneer of office and hospital-based, non-invasive systems for measurement of heart rate variability, today announced that the United States Food & Drug Administration (FDA) has given the Company extended clearance to market its heart rate variability test, called the Anscore Health Management System.
An office-based heart rate variability test fills this critical information gap for both physician and patient.
The expanded sales force will be responsible for generating sales of the Anscore(TM) Health Management System, the Company's heart rate variability test, in their assigned regions as well as to educate and train healthcare professionals and develop close ties with the physician community.